Together against Covid-19 pandemic
In these difficult times dominated by the Covid-19 pandemic, BioRN is taking actions to support the global life science community in our networking function. BioRN community - as one of the strongest life science networks in Europe, can strongly contribute to the fight against the SARS-CoV-2 virus.
Scroll down for current 'Offer' and 'Search' ads.
Please submit your contribution to info[at]biorn.org.
Form-Together against Covid-19 Pandemic
OFFER
Dose finding for new vaccines and drugs, Clinical Trial Design (sample size calculations etc.), Translational PK/PD modelling, Analysis of large omics datasets.
Click on 'more'
SEARCH
Collaborators who are interested in partnering with EVI for the development of a Covid-19 vaccine.
Click on 'more'
OFFER
We help sponsors develop innovative adaptive study design with very rapid turn-around (24-48 hours), enabling fast review and regulatory engagements.
Click on 'more'
OFFER
Textile face masks, reusable, washable (min 85°C), OEKO-TEX certification.
Large quantities, min 50.000, 2€ (+VAT) per mask. Delivery within 2 weeks.
Click on 'more'
OFFER
Products and Services enabling SARS-CoV-2 Studies, e.g. iSWAB Sample Collection Tubes, Host Cell Entry Factor Expression Constructs and Cell Lines, Virus Entry Factor Expression Constructs, spike-Protein Pseudotyped Lentiviral Particles,
Click on 'more'
SEARCH
Casein (fatty acid free, for blocking coated microtiter plates, currently supply is limited)
Click on 'more'
SEARCH
Academic groups or biotech/pharma companies working on anti SARS CoV 2 antibodies.
Click on 'more'
OFFER
A professional information search service in the area of patents and literature around COVID 19, public-free data, public hidden-data and commercial available data
Click on 'more'
SEARCH
Clinical partners with relevant biological sample cohorts such as COVID-19 positive tested patients (acute phase and post-infection), preferably plasma/serum.
Click on 'more'
OFFER
Pragmatic and straight-forward IP advice at special rates regarding the protection of IP and contractual agreements needed to tackle the challenges of Covid-19 pandemic.
Click on 'more'
OFFER
Collagen Materials for cell culture
Cell culture facilities
Fluorescent microscopy
Molecular biology lab (including PCR)
Click on 'more'
OFFER
SARS-CoV-2 RNA purification and RT-PCR kits, NGS panels, recombinant proteins, antibodies, IgM/IgG detection kits, ELISA, compound libraries and antiviral agents.
Click on 'more'
SEARCH
We are looking to connect to biotechnology or pharmaceutical companies and research facilities who are involved in cancer & stem cell research and/or 3D cell culture.
Click on 'more'
SEARCH
peripheral blood mononuclear cells and/or isolated T and B cell fractions patients and healthy controls.
Click on 'more'
OFFER
Anti SARS CoV 2 ELISA E111 IVD: a highly specific enzyme immunoassay for the detection of antibodies against the SARS CoV 2 S1 receptor binding domain (RBD) in human blood.
Click on 'more'
SEARCH
COVID-19 antibody related products i.e. standalone antibodies, conjugated antibodies, COVID -19 antigens & recombinant proteins.
Click on 'more'
OFFER
Legal advice of any form with respect to current commercial/legal situation in crises as well as their R&D operations, relative to the CORONA pandemic or other.
Click on 'more'
OFFER
Recombinant SARS-CoV-2 proteins which can be used as antigen or control protein for analytic and diagnostic purposes as well as for vaccine development.
Click on 'more'
OFFER
Biomanufacturing technology and services for scaling up COVID-19 vaccine candidate production
Click on 'more'
OFFER
Analytical support for vaccine, gene therapy or antibody product development.
Click on 'more'
OFFER
Broad coverage of metabolic pathways
Many immunomodulatory pathways analyzed
Quantitative and reproducible results
Innovative kit design
Click on 'more'
OFFER
Data analysis, on demand data reporting, statistical support, programming capacities in R and SAS
Click on 'more'
OFFER
fightCOVID@DKFZ, a collaboration among DKFZ, university hospitals in Heidelberg and Mannheim.
Prof. Dr. Ralf Bartenschlager
Dr. Catherine Moreau
SEARCH
Antibody against the human ACE2 Receptor for the characterization of a cell line
Click on 'more'
SEARCH
We are offering a grant comprising up to 250,000 €/year for 3 years. Proposals will be considered that leverage technological solutions to be prepared for pandemic outbreaks or to fight emerging viral infections.
OFFER
qPCR instrument (depending on urgency of the situation)
Coating of microtiter plates for Covid-19 immuno-assays (ELISA)
Lab technicians (on voluntary basis)
Click on 'more'
OFFER
Multiplex protein profiling services for acceleration of COVID 19 research
Click on 'more'
OFFER
analytical and clinical performance evaluation for COVID-19 diagnostic kit
collection of Covid-19 patient samples
S2 contract lab
Click on 'more'
OFFER
Coronavirus S-protein pseudotyped lentivirus; Recombinant coronavirus vectors (25+ species); Cell line models for Corona-related research; Animal models for Corona-related research
Click on 'more'